OPINION
The various plaintiffs and intervenors (appellants) appeal from the trial court’s grant of a motion to dismiss in favor of Shrake’s Country Club Pharmacy, Inc. (Shrake’s). The trial court held that a pharmacy has no duty to warn either the customer or his physician that prolonged use of a prescription drug dispensed by the pharmacy or use of the drug in combination with another prescribed drug may lead to addiction or adverse side-effects. We hold that the pharmacy owed the customer a duty of reasonable care and that the trial court therefore erred in holding as a matter of law that Shrake’s had no duty to warn.
I.
In an appeal from the grant of a motion to dismiss for failure to state a claim upon which relief can be granted, we assume the truth of all the complaint’s material allegations and accord the appellants the benefit of all inferences reasonably supported by the complaint.
See Sun World Corp. v. Pennysaver, Inc.,
II.
From 1960 to 1990, William K. Helms, M.D. (Helms) treated appellant George Las-ley (Lasley). Helms prescribed Doriden and codeine, which Lasley alleges are potent and addicting drugs. Lasley filled most of the prescriptions from Helms at Shrake’s. For approximately ten years, Shrake’s mailed one or more of the allegedly addictive drugs to Lasley at his residence in another state.
Allegedly as a result of taking Doriden and codeine for an extended period of time and in combination, Lasley required in-patient hospitalization for Doriden detoxification and psychiatric treatment for addiction. He suffered from a major clinical depression and related disorders.
In March 1991, appellants filed their complaint against Helms and Shrake’s. 1 Appellants alleged that Shrake’s had breached a duty to Lasley “to exercise that degree of care, skill and learning expected of reasonable prudent pharmacies and pharmacists in the profession.” Shrake’s filed a motion to dismiss for failure to state a claim upon which relief could be granted. It argued that, as a matter of law, a pharmacist has neither a duty to warn of a prescribed drug’s dangerous propensities nor a duty to control or keep track of a customer’s reliance on drugs prescribed by a licensed treating physician.
In response, appellants argued that Shrake’s owed a duty of reasonable care to Lasley and that whether it had breached the standard of care applicable to that duty was a question for the trier of fact. They presented to the trial court an affidavit from an expert and portions of the American Pharmaceutical Association Standards of Practice for the Profession of Pharmacy. Those documents indicated that the standard of care for a pharmacist includes obligations to advise a customer of the highly addictive nature of a prescribed drug and of the hazards of ingesting two or more drugs that adversely interact with one another. Appellants’ evidence further stated that a pharmacist should advise the prescribing doctor if it appears that the patient is taking an addictive drug in quantities inconsistent with the manufacturer’s recommended dosage guidelines.
The trial court granted the motion to dismiss. It found that Shrake’s owed no duty to appellants to warn of addiction or to refuse prescriptions written by Helms. Following denial of appellants’ motion for reconsideration, the trial court entered judgment dismissing the complaint against Shrake’s with prejudice. Appellants timely appealed from the judgment.
III.
A
Because this is a negligence action, we first determine whether Shrake’s had “a duty to conform to a particular standard of conduct to protect [Lasley] against unreasonable risks of harm.”
Alhambra School Dist. v. Maricopa County Superior Court,
Shrake’s contends that the trial court correctly ruled that Shrake’s had no duty to warn Lasley or his physician of the potentially addictive nature of drugs legiti
In
Markowitz,
the Arizona Supreme Court cautioned against confusing the existence of a duty with details of the standard of conduct.
It is better to reserve “duty” for the problem of the relation between individuals which imposes upon one a legal obligation for the benefit of the other, and to deal with particular conduct in terms of a legal standard of what is required to meet the obligation. In other words, “duty” is a question of whether the defendant is under any obligation for the benefit of the particular plaintiff; and in negligence cases, the duty [if it exists] is always the same—to conform to the legal standard of reasonable conduct in the light of the apparent risk. What the defendant must do, or must not do, is a question of the standard of conduct required to satisfy the duty.
In its answer, Shrake’s admitted that it owed a duty to Lasley to comply with the applicable standard of care. We agree. Thus, the answer to the threshold question in this appeal is that Shrake’s did owe a duty of reasonable care to Lasley. The trial court therefore erred in finding, as a matter of law, that Shrake’s owed no duty to Lasley.
B.
Once the court determines that a duty exists, the next question is whether the defendant breached the standard of care established pursuant to the duty.
Markowitz,
In an ordinary negligence action, the standard of care imposed is that of the conduct of a reasonably prudent person under the circumstances.
Bell v. Maricopa Medical Ctr.,
Arizona courts have not yet considered whether the scope of a pharmacist’s duty of reasonable care includes an obligation to warn customers of possible adverse effects of prescribed medications. Other jurisdictions, however, have resolved this question, and we look to their decisions for guidance.
See Bellezzo,
As Shrake’s asserts, the majority of jurisdictions that have considered the scope of a pharmacist’s duty to warn customers have concluded, in various factual settings, that no such duty exists. Some courts,, rsnsidering whether a pharmacist has a duty to warn the customer of possible adverse side effects of prescribed medications, have held no such duty exists. 2 In these cases, the courts generally reason that imposing a duty to warn on the pharmacist would place the pharmacist between the physician, who knows the patient’s physical condition, and the patient and that recognizing such a duty could lead to harmful interference in the patient-physician relationship. 3
Other courts, considering the duty to warn in a factual situation similar to that before us, have concluded that pharmacists have no legal duty to warn the patient or physician when the physician prescribes excessive doses of a drug. 4 Those courts conclude that the physician, not the pharmacist, has the duty to prescribe drugs properly and to warn the patient of any dangers from taking the medication. Imposing a duty to warn on pharmacists would compel them to second guess every prescription physicians write if the pharmacists wished to escape liability. 5
Other jurisdictions, applying the same distinction between duty and standard of conduct as that explained in
Markowitz,
have concluded that whether a failure to warn violates the applicable standard of conduct in a particular situation generally presents a question of fact for the jury. In
Dooley v. Everett,
The
Dooley
court first noted the distinction between duty and standard of care and determined that the pharmacy owed its customer a duty to use due care under the attendant circumstances.
Similarly, in
Hand v. Krakowski,
In response to Shrake’s motion to dismiss, appellants presented an affidavit from an expert stating that the standard of care applicable to a pharmacist includes a responsibility to advise a customer of the addictive nature of a drug, to warn of the hazards of ingesting two or more drugs that adversely interact with one another, and to discuss with the physician the addictive nature of a prescribed drug and the dangers of long-term prescription of the drug. Appellants also presented excerpts from the American Pharmaceutical Association Standards of Practice for the Profession of Pharmacy that described similar standards. On this record, we cannot say as a matter of law that Shrake’s did not breach the standard of care • for the duty it owed to Lasley.
IV.
For the reasons explained above, we reverse the trial court’s grant of summary judgment in favor of Shrake’s and remand to the trial court for further proceedings.
Notes
. Helms is not party to this appeal.
.
See Ramirez
v.
Richardson-Merrell, Inc.,
.
See Ramirez,
.
See Jones
v.
Irvin,
.
See Jones,
